Home ›› 06 Oct 2020 ›› World Biz
Central Pharmaceuticals Ltd, a listed company in the Dhaka Stock Exchange (DSE), has revealed its revised earnings per share (EPS) for the period from Jan-March, 2020, after making a mistake in the earlier declared earnings per share (EPS) figures.
In the company’s un-audited Q3 statements, the earnings per share (EPS) would be 0.18 taka instead of 0.07 taka and the earning per share (EPS) for the period from July 2019-March 2020 would be 0.07 taka instead of 0.18 taka.
The revelation was confirmed on the DSE website Tuesday.
However, other information of the earlier disclosure will remain unchanged.
